MYP_116705
Basic Information
T-267226
Antimicrobial
Antiviral
Antiviral Anti-HIV
Antiviral Antiviral mechanism Viral fusion inhibition
Antiviral Antiviral mechanism Viral fusion inhibition Fusion inhibitor
Standard
38 amino acids
C194H308N56O61
Standard
Sequence
TTWEAWDRAIAEYAARIEALIRAAQELQEKNEAALREL
Physicochemical Analysis
4400.86 Da
4.64
-3.58
-3.79
-0.0943
-0.48
0.69
-0.10
45.38
98.16
0.0789
12490.00
12490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1933.58
-15.87
68.0
58.0
148.0
311.0
5.0
40.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0323208 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral
098-T651 virus
0.020 μg/mL
IC50
Male cynomolgus monkey blood plasma (Intravenous), in vivo; 27360 s
RECORD: Rec_0385332 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
HIV-1 IIIB
RECORD: Rec_0398356 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral
098
0.021 μg/mL
IC50
Male cynomolgus monkey blood plasma (Intravenous), in vivo; 27360 s
FIRST PREV 1 2 3 4
Showing 3 records on this page · Page 4 of 4